Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spirit Scientific CoROCO:7790 21 Return-on-Tangible-Equity is 1.05% as of Dec. 2025, which is 56% below its 10-year median of 2.37. GuruFocus rates ROCO:7790 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 1,199 Biotechnology companies, Spirit Scientific Co ranks better than 78.57% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Spirit Scientific Co's annualized net income for the quarter that ended in Dec. 2025 was NT$4.0 Mil. Spirit Scientific Co's average shareholder tangible equity for the quarter that ended in Dec. 2025 was NT$381.4 Mil. Therefore, Spirit Scientific Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 1.05%.
The historical rank and industry rank for Spirit Scientific Co's Return-on-Tangible-Equity or its related term are showing as below:
ROCO:7790'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -10.78 Med: 2.37 Max: 5.62
Current: 1.41
During the past 5 years, Spirit Scientific Co's highest Return-on-Tangible-Equity was 5.62%. The lowest was -10.78%. And the median was 2.37%.
ROCO:7790's Return-on-Tangible-Equity is ranked better than 78.57% of 1199
companies
in the Biotechnology industry
Industry Median: -42.4
vs ROCO:7790: 1.41
Spirit Scientific Co (ROCO:7790) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Spirit Scientific Co Return-on-Tangible-Equity Related Terms
Spirit Scientific Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Spirit Scientific Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spirit Scientific Co Return-on-Tangible-Equity Chart
ROCO:7790 vs VRTX, REGN, ALNY: Return-on-Tangible-Equity Comparison
For the Biotechnology subindustry, Spirit Scientific Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spirit Scientific Co Return-on-Tangible-Equity vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Spirit Scientific Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Spirit Scientific Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 1.05% mean?
Spirit Scientific Co (ROCO:7790) has a Return-on-Tangible-Equity of 1.05% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Spirit Scientific Co and its competitors. This is 56% below median its historical median of 2.37. According to the industry distribution chart, Spirit Scientific Co ranks #257 out of 1199 companies in the Biotechnology industry, placing it in the top 21.4%.
Is Spirit Scientific Co's Return-on-Tangible-Equity too high?
Spirit Scientific Co's current Return-on-Tangible-Equity of 1.05% is 56% below median its 10-year median of 2.37. Based on the distribution chart, Spirit Scientific Co ranks #257 out of 1199 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Spirit Scientific Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Spirit Scientific Co's Return-on-Tangible-Equity compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Spirit Scientific Co ranks #257 out of 1199 companies for Return-on-Tangible-Equity. This places Spirit Scientific Co in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Biotechnology company?
A good Return-on-Tangible-Equity depends on the Biotechnology industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Spirit Scientific Co and its competitors. Spirit Scientific Co's current Return-on-Tangible-Equity is 1.05%, which is 56% below median its own 10-year median of 2.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spirit Scientific Co stock overvalued right now?
Spirit Scientific Co (ROCO:7790) has a current Return-on-Tangible-Equity of 1.05%. The current Return-on-Tangible-Equity is 1.05%, which is 56% below median its 10-year median of 2.37. Spirit Scientific Co's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Spirit Scientific Co (ROCO:7790), the current Return-on-Tangible-Equity is 1.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Spirit Scientific Co Ltd is engaged in precision regenerative medicine, specializing in platelet cryocrystallization technology and Bio Material Lyophilized Technology (BMLT). The company provides solutions for extracting high-concentration platelet growth factors, enabling safe, flexible, and long-term storage therapies. Spirit Biotech delivers cutting-edge autologous healing reagent preparation services, along with OEM and ODM models. With a focus on unmet medical needs, the company transforms patented technologies into scalable solutions, advancing the future of regenerative healthcare.
21GF Score
Get the complete analysis for ROCO:7790
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7790 has been successfully added to your 
